Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14242
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Aroonrerk N. | |
dc.contributor.author | Changtam C. | |
dc.contributor.author | Kirtikara K. | |
dc.contributor.author | Suksamrarn A. | |
dc.date.accessioned | 2021-04-05T03:33:45Z | - |
dc.date.available | 2021-04-05T03:33:45Z | - |
dc.date.issued | 2012 | |
dc.identifier.issn | 19917902 | |
dc.identifier.other | 2-s2.0-84872167777 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14242 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872167777&doi=10.1016%2fj.jds.2012.09.023&partnerID=40&md5=b06e1912c299cbd8fe8f45b59bbcd004 | |
dc.description.abstract | Background/purpose: Curcumin is a polyphenolic phytochemical isolated from the medicinal plant Curcuma longa L. This phytochemical exhibits anti-inflammatory and antioxidant properties. The aim of this study was to find a curcuminoid compound that has a better effect on the suppression of interleukin-1β (IL-1β)-induced IL-6 production than curcumin in human gingival fibroblasts (HGFs). Materials and methods: The parent curcuminoids 1-3 were isolated from the rhizomes of C. longa and 17 curcuminoid analogs 4-20 were synthesized from the parent curcuminoids. The condition for IL-6 production by HGFs after inducing the cells with IL-1β was optimized. HGFs were incubated with curcuminoids (0.016-20 μg/mL) for 30 minutes before adding IL-1β (2 ng/mL). After 24 hours of incubation, the culture media were harvested and determined for IL-6 contents using an enzyme-linked immunosorbent assay method. Prednisolone, an immunosuppressive drug, was used as a positive control. Half maximal effective concentration (EC50) is measured and reported as the concentration required for 50% inhibition of the levels found in the control medium. Results: The maximum IL-6 production was achieved when the HGFs were exposed to an IL-1β concentration of 2 ng/mL for 24 hours; however, addition of the immunosuppressant prednisolone inhibited the production of IL-6. Among the analogs, di-O-demethylcurcumin (5) exhibited the most potent anti-IL-6 activity with an EC50 of 2.18 ± 0.07 μg/mL, which was approximately eightfold more active than the natural curcuminoids 1-3. Cell viability was not significantly affected when the concentration of di-O-demethylcurcumin was less than 20 μg/mL. Conclusion: Di-O-demethylcurcumin exhibited an inhibitory effect on the production of IL-6 by IL-1β-induced HGFs and can thus serve as a lead compound with its inhibiting property for IL-6 production. Copyright © 2012, Association for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved. | |
dc.title | Inhibitory effects of di-O-demethylcurcumin on interleukin-1β-induced interleukin-6 production from human gingival fibroblasts | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Journal of Dental Sciences. Vol 7, No.4 (2012), p.350-358 | |
dc.identifier.doi | 10.1016/j.jds.2012.09.023 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.